Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 127 entries
Sorted by: Best Match Show Resources per page
An Apparatus for Continuous Oiling of Streams.

The Indian medical gazette

Michelson EG.
PMID: 29014311
Ind Med Gaz. 1938 Oct;73(10):612.

No abstract available.

Cite
Michelson EG. An Apparatus for Continuous Oiling of Streams. Ind Med Gaz. 1938;73(10):612
Michelson, E. G. (1938). An Apparatus for Continuous Oiling of Streams. The Indian medical gazette, 73(10), 612.
Michelson, E G. "An Apparatus for Continuous Oiling of Streams." The Indian medical gazette vol. 73,10 (1938): 612.
Michelson EG. An Apparatus for Continuous Oiling of Streams. Ind Med Gaz. 1938 Oct;73(10):612. PMID: 29014311; PMCID: PMC5219366.
Copy Download .nbib Format: NLM
Aural vignettes of dermatologic history. Interview by Victor H Witten.

Cutis

Michelson H.
PMID: 9403239
Cutis. 1997 Nov;60(5):232-4.

No abstract available.

Cite
Michelson H. Aural vignettes of dermatologic history. Interview by Victor H Witten. Cutis. 1997;60(5):232-4
Michelson, H. (1997). Aural vignettes of dermatologic history. Interview by Victor H Witten. Cutis, 60(5), 232-4.
Michelson, H. "Aural vignettes of dermatologic history. Interview by Victor H Witten." Cutis vol. 60,5 (1997): 232-4.
Michelson H. Aural vignettes of dermatologic history. Interview by Victor H Witten. Cutis. 1997 Nov;60(5):232-4. PMID: 9403239.
Copy Download .nbib Format: NLM
The Linguistic Classification of Potawatomi.

Proceedings of the National Academy of Sciences of the United States of America

Michelson T.
PMID: 16576042
Proc Natl Acad Sci U S A. 1915 Aug;1(8):450-2. doi: 10.1073/pnas.1.8.450.

No abstract available.

Cite
Michelson T. The Linguistic Classification of Potawatomi. Proc Natl Acad Sci U S A. 1915;1(8):450-2doi: 10.1073/pnas.1.8.450.
Michelson, T. (1915). The Linguistic Classification of Potawatomi. Proceedings of the National Academy of Sciences of the United States of America, 1(8), 450-2. https://doi.org/10.1073/pnas.1.8.450
Michelson, T. "The Linguistic Classification of Potawatomi." Proceedings of the National Academy of Sciences of the United States of America vol. 1,8 (1915): 450-2. doi: https://doi.org/10.1073/pnas.1.8.450
Michelson T. The Linguistic Classification of Potawatomi. Proc Natl Acad Sci U S A. 1915 Aug;1(8):450-2. doi: 10.1073/pnas.1.8.450. PMID: 16576042; PMCID: PMC1090856.
Copy Download .nbib Format: NLM
Perspectives in biomedical supercomputing.

IEEE engineering in medicine and biology magazine : the quarterly magazine of the Engineering in Medicine & Biology Society

Laxminarayan S, Michelson L.
PMID: 18244075
IEEE Eng Med Biol Mag. 1988;7(4):12-5. doi: 10.1109/51.20374.

Recent major developments in supercomputer technology are outlined. Areas of interest in biomedical supercomputing that are discussed are: (1) molecular modeling and dynamics; (2) medical imaging and signals processing; (3) modeling and simulation of complex physiological systems; (4) genetic...

Cite
Laxminarayan S, Michelson L. Perspectives in biomedical supercomputing. IEEE Eng Med Biol Mag. 1988;7(4):12-5doi: 10.1109/51.20374.
Laxminarayan, S., & Michelson, L. (1988). Perspectives in biomedical supercomputing. IEEE engineering in medicine and biology magazine : the quarterly magazine of the Engineering in Medicine & Biology Society, 7(4), 12-5. https://doi.org/10.1109/51.20374
Laxminarayan, S, and Michelson, L. "Perspectives in biomedical supercomputing." IEEE engineering in medicine and biology magazine : the quarterly magazine of the Engineering in Medicine & Biology Society vol. 7,4 (1988): 12-5. doi: https://doi.org/10.1109/51.20374
Laxminarayan S, Michelson L. Perspectives in biomedical supercomputing. IEEE Eng Med Biol Mag. 1988;7(4):12-5. doi: 10.1109/51.20374. PMID: 18244075.
Copy Download .nbib Format: NLM
AMERICAN LINGUISTICS.

Science (New York, N.Y.)

Michelson T.
PMID: 17847298
Science. 1932 Jul 15;76(1959):55-6. doi: 10.1126/science.76.1959.55-a.

No abstract available.

Cite
Michelson T. AMERICAN LINGUISTICS. Science. 1932;76(1959):55-6doi: 10.1126/science.76.1959.55-a.
Michelson, T. (1932). AMERICAN LINGUISTICS. Science (New York, N.Y.), 76(1959), 55-6. https://doi.org/10.1126/science.76.1959.55-a
Michelson, T. "AMERICAN LINGUISTICS." Science (New York, N.Y.) vol. 76,1959 (1932): 55-6. doi: https://doi.org/10.1126/science.76.1959.55-a
Michelson T. AMERICAN LINGUISTICS. Science. 1932 Jul 15;76(1959):55-6. doi: 10.1126/science.76.1959.55-a. PMID: 17847298.
Copy Download .nbib Format: NLM
The future of predictive biosimulation in drug discovery.

Expert opinion on drug discovery

Michelson S, Cole M.
PMID: 23484759
Expert Opin Drug Discov. 2007 Apr;2(4):515-23. doi: 10.1517/17460441.2.4.515.

Biosimulation and mathematical modeling are powerful approaches for characterizing complex biological systems and their dynamic evolution. The modeling process enables research scientists to systematically identify critical gaps in their knowledge and explicitly formulate candidate hypotheses to span them. Biosimulations...

Cite
Michelson S, Cole M. The future of predictive biosimulation in drug discovery. Expert Opin Drug Discov. 2007;2(4):515-23doi: 10.1517/17460441.2.4.515.
Michelson, S., & Cole, M. (2007). The future of predictive biosimulation in drug discovery. Expert opinion on drug discovery, 2(4), 515-23. https://doi.org/10.1517/17460441.2.4.515
Michelson, Seth, and Cole, Mike. "The future of predictive biosimulation in drug discovery." Expert opinion on drug discovery vol. 2,4 (2007): 515-23. doi: https://doi.org/10.1517/17460441.2.4.515
Michelson S, Cole M. The future of predictive biosimulation in drug discovery. Expert Opin Drug Discov. 2007 Apr;2(4):515-23. doi: 10.1517/17460441.2.4.515. PMID: 23484759.
Copy Download .nbib Format: NLM
Diffusion tensor imaging for in vivo detection of degenerated optic radiation.

ISRN ophthalmology

Michelson G, Engelhorn T, Waerntges S, Doerfler A.
PMID: 24533184
ISRN Ophthalmol. 2011 Dec 27;2011:648450. doi: 10.5402/2011/648450. eCollection 2011.

Glaucomatous optic nerve atrophy may continue to the linked optic radiation by transneuronal degeneration, as described in animal models of glaucoma. In vivo visualization of the visual pathway represents a new challenge in the field of ophthalmology. We present...

Cite
Michelson G, Engelhorn T, Waerntges S, et al. Diffusion tensor imaging for in vivo detection of degenerated optic radiation. ISRN Ophthalmol. 2011;2011:648450doi: 10.5402/2011/648450.
Michelson, G., Engelhorn, T., Waerntges, S., & Doerfler, A. (2011). Diffusion tensor imaging for in vivo detection of degenerated optic radiation. ISRN ophthalmology, 2011648450. https://doi.org/10.5402/2011/648450
Michelson, Georg, et al. "Diffusion tensor imaging for in vivo detection of degenerated optic radiation." ISRN ophthalmology vol. 2011 (2011): 648450. doi: https://doi.org/10.5402/2011/648450
Michelson G, Engelhorn T, Waerntges S, Doerfler A. Diffusion tensor imaging for in vivo detection of degenerated optic radiation. ISRN Ophthalmol. 2011 Dec 27;2011:648450. doi: 10.5402/2011/648450. eCollection 2011. PMID: 24533184; PMCID: PMC3912596.
Copy Download .nbib Format: NLM
Effects of the implantation of oxygen, nitrogen, and carbon on the density of states of n-type hydrogenated amorphous silicon.

Physical review. B, Condensed matter

Cohen JD, Michelson CE.
PMID: 9993869
Phys Rev B Condens Matter. 1990 Jan 15;41(3):1529-1541. doi: 10.1103/physrevb.41.1529.

No abstract available.

Cite
Cohen JD, Michelson CE. Effects of the implantation of oxygen, nitrogen, and carbon on the density of states of n-type hydrogenated amorphous silicon. Phys Rev B Condens Matter. 1990;41(3):1529-1541doi: 10.1103/physrevb.41.1529.
Cohen, J. D., & Michelson, C. E. (1990). Effects of the implantation of oxygen, nitrogen, and carbon on the density of states of n-type hydrogenated amorphous silicon. Physical review. B, Condensed matter, 41(3), 1529-1541. https://doi.org/10.1103/physrevb.41.1529
Cohen, and Michelson. "Effects of the implantation of oxygen, nitrogen, and carbon on the density of states of n-type hydrogenated amorphous silicon." Physical review. B, Condensed matter vol. 41,3 (1990): 1529-1541. doi: https://doi.org/10.1103/physrevb.41.1529
Cohen JD, Michelson CE. Effects of the implantation of oxygen, nitrogen, and carbon on the density of states of n-type hydrogenated amorphous silicon. Phys Rev B Condens Matter. 1990 Jan 15;41(3):1529-1541. doi: 10.1103/physrevb.41.1529. PMID: 9993869.
Copy Download .nbib Format: NLM
Cardiac Safety Research Consortium (CSRC): Cardiovascular Safety and Adverse Event Case Report Forms.

Therapeutic innovation & regulatory science

Sabol ME, Finkle J, Krucoff M, Stockbridge N, Parkhill N, Shinagawa K, Mahaffey K, Tcheng J, Lenihan D, Melloni C, Todaro T, Michelson E, Munley J, Zander J, Oh R.
PMID: 30222439
Ther Innov Regul Sci. 2015 Jul;49(4):511-513. doi: 10.1177/2168479014567319.

Detection of off-target cardiovascular (CV) effects remains a significant challenge to drug development. Documentation of CV events in non-CV trials is often inadequate to interpret imbalances between treatment arms, which may lead to concerns about potential CV safety "signals."...

Cite
Sabol ME, Finkle J, Krucoff M, et al. Cardiac Safety Research Consortium (CSRC): Cardiovascular Safety and Adverse Event Case Report Forms. Ther Innov Regul Sci. 2015;49(4):511-513doi: 10.1177/2168479014567319.
Sabol, M. E., Finkle, J., Krucoff, M., Stockbridge, N., Parkhill, N., Shinagawa, K., Mahaffey, K., Tcheng, J., Lenihan, D., Melloni, C., Todaro, T., Michelson, E., Munley, J., Zander, J., & Oh, R. (2015). Cardiac Safety Research Consortium (CSRC): Cardiovascular Safety and Adverse Event Case Report Forms. Therapeutic innovation & regulatory science, 49(4), 511-513. https://doi.org/10.1177/2168479014567319
Sabol, Mary Elizabeth, et al. "Cardiac Safety Research Consortium (CSRC): Cardiovascular Safety and Adverse Event Case Report Forms." Therapeutic innovation & regulatory science vol. 49,4 (2015): 511-513. doi: https://doi.org/10.1177/2168479014567319
Sabol ME, Finkle J, Krucoff M, Stockbridge N, Parkhill N, Shinagawa K, Mahaffey K, Tcheng J, Lenihan D, Melloni C, Todaro T, Michelson E, Munley J, Zander J, Oh R. Cardiac Safety Research Consortium (CSRC): Cardiovascular Safety and Adverse Event Case Report Forms. Ther Innov Regul Sci. 2015 Jul;49(4):511-513. doi: 10.1177/2168479014567319. PMID: 30222439.
Copy Download .nbib Format: NLM
The significant cost of systematic reviews and meta-analyses: A call for greater involvement of machine learning to assess the promise of clinical trials.

Contemporary clinical trials communications

Michelson M, Reuter K.
PMID: 31497675
Contemp Clin Trials Commun. 2019 Aug 25;16:100443. doi: 10.1016/j.conctc.2019.100443. eCollection 2019 Dec.

BACKGROUND: More than 90% of clinical-trial compounds fail to demonstrate sufficient efficacy and safety. To help alleviate this issue, systematic literature review and meta-analysis (SLR), which synthesize current evidence for a research question, can be applied to preclinical evidence...

Cite
Michelson M, Reuter K. The significant cost of systematic reviews and meta-analyses: A call for greater involvement of machine learning to assess the promise of clinical trials. Contemp Clin Trials Commun. 2019;16:100443doi: 10.1016/j.conctc.2019.100443.
Michelson, M., & Reuter, K. (2019). The significant cost of systematic reviews and meta-analyses: A call for greater involvement of machine learning to assess the promise of clinical trials. Contemporary clinical trials communications, 16100443. https://doi.org/10.1016/j.conctc.2019.100443
Michelson, Matthew, and Reuter, Katja. "The significant cost of systematic reviews and meta-analyses: A call for greater involvement of machine learning to assess the promise of clinical trials." Contemporary clinical trials communications vol. 16 (2019): 100443. doi: https://doi.org/10.1016/j.conctc.2019.100443
Michelson M, Reuter K. The significant cost of systematic reviews and meta-analyses: A call for greater involvement of machine learning to assess the promise of clinical trials. Contemp Clin Trials Commun. 2019 Aug 25;16:100443. doi: 10.1016/j.conctc.2019.100443. eCollection 2019 Dec. PMID: 31497675; PMCID: PMC6722281.
Copy Download .nbib Format: NLM
Design and Development of the ".

Frontiers in public health

Gonsalves PP, Hodgson ES, Kumar A, Aurora T, Chandak Y, Sharma R, Michelson D, Patel V.
PMID: 31508404
Front Public Health. 2019 Aug 23;7:238. doi: 10.3389/fpubh.2019.00238. eCollection 2019.

No abstract available.

Cite
Gonsalves PP, Hodgson ES, Kumar A, et al. Design and Development of the ". Front Public Health. 2019;7:238doi: 10.3389/fpubh.2019.00238.
Gonsalves, P. P., Hodgson, E. S., Kumar, A., Aurora, T., Chandak, Y., Sharma, R., Michelson, D., & Patel, V. (2019). Design and Development of the ". Frontiers in public health, 7238. https://doi.org/10.3389/fpubh.2019.00238
Gonsalves, Pattie P, et al. "Design and Development of the "." Frontiers in public health vol. 7 (2019): 238. doi: https://doi.org/10.3389/fpubh.2019.00238
Gonsalves PP, Hodgson ES, Kumar A, Aurora T, Chandak Y, Sharma R, Michelson D, Patel V. Design and Development of the ". Front Public Health. 2019 Aug 23;7:238. doi: 10.3389/fpubh.2019.00238. eCollection 2019. PMID: 31508404; PMCID: PMC6716539.
Copy Download .nbib Format: NLM
At a Crossroads: A Perspective on Drug Development for Alzheimer's Disease in 2016.

The journal of prevention of Alzheimer's disease

Michelson D, Egan M.
PMID: 29199317
J Prev Alzheimers Dis. 2016;3(4):181-184. doi: 10.14283/jpad.2016.106.

No abstract available.

Cite
Michelson D, Egan M. At a Crossroads: A Perspective on Drug Development for Alzheimer's Disease in 2016. J Prev Alzheimers Dis. 2016;3(4):181-184doi: 10.14283/jpad.2016.106.
Michelson, D., & Egan, M. (2016). At a Crossroads: A Perspective on Drug Development for Alzheimer's Disease in 2016. The journal of prevention of Alzheimer's disease, 3(4), 181-184. https://doi.org/10.14283/jpad.2016.106
Michelson, D, and Egan, M. "At a Crossroads: A Perspective on Drug Development for Alzheimer's Disease in 2016." The journal of prevention of Alzheimer's disease vol. 3,4 (2016): 181-184. doi: https://doi.org/10.14283/jpad.2016.106
Michelson D, Egan M. At a Crossroads: A Perspective on Drug Development for Alzheimer's Disease in 2016. J Prev Alzheimers Dis. 2016;3(4):181-184. doi: 10.14283/jpad.2016.106. PMID: 29199317.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 127 entries